← All stocks

Chemomab Therapeutics Ltd.

CMMB Net selling

CIK 0001534248 #5140 in the set updated 17 Sep 2026

Bought (120 mo)

$194.95K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$2.50M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$2.50M

9 of 9 sales

Net

−$2.31M

−$2.31M against sales at will

By person

9 insiders · 32 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mor George Adi

Chief Executive Officer

$20.25K (2)

$1.28M (4)

−$1.26M

269,897

0.0469%

$755.71K

−70.9%

OrbiMed Israel GP Ltd. entity

10% owner

—

$1.21M (2)

−$1.21M

4,819,448

0.8376%

$13.49M

−1.0%

Cohen Neil Harris

Director

$147.36K (6)

$11.33K (3)

+$136.02K

33,000

0.0057%

$92.40K

+30.4%

Pfost Dale R

Chief Executive Officer

$9.94K (2)

—

+$9.94K

2,500

0.0004%

$7.00K

—

Marvin Donald

Executive VP, CFO & COO

$6.68K (7)

—

+$6.68K

2,000

0.0003%

$5.60K

+700.0%

Maryles Joel Michael

Director

$5.59K (4)

—

+$5.59K

1,433

0.0002%

$4.01K

—

Darvish Nissim

Director

$5.14K (1)

—

+$5.14K

1,200

0.0002%

$3.36K

—

THIEL PETER

10% owner

— (1)

—

$0.00

1,108,509

0.1927%

$3.10M

+26.3%

SQUINTO STEPHEN P

Director

—

47,938

0.0083%

$134.23K

0.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 39

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 9

Transactions with no price 1

Shares from compensation/vesting 338,632

Sales filed before the plan box existed 7

History held since 11 Mar 2021